Why Hims & Hers Health Stock Just Crashed
Hims & Hers Health (NYSE: HIMS) stock tumbled 12% through 11:15 a.m. ET Tuesday after missing badly on Q1 earnings last night.
Heading into the report, analysts forecast the telehealth company, made famous for selling discount GLP-1 weight loss drugs (and getting sued repeatedly for it), would earn a tiny $0.01 per share profit on sales of $616.5 million. In fact, Hims & Hers lost $0.40 per share, and revenue was only $608 million.
Image source: Getty Images.
Source Fool.com
